Cardiology
News, opinions and meeting coverage in cardiology.
— Also in TTHealthWatch: testosterone supplements and the heart
Latest in Cardiology
Local Superfund site may contribute to inorganic arsenic exposure
But experts disagree about what the findings actually mean
Infusion made from deceased donor pancreatic islet cells
But D-Health Trial investigators hold out hope supplements may still help selected patients
Infusion made from deceased donor pancreatic islet cells
But D-Health Trial investigators hold out hope supplements may still help selected patients
Cardiology Case Studies
Idiopathic ventricular fibrillation can affect people with no clinical evidence of heart disease
Patient recovered quickly, thanks to cardiologist's fast response
Symptoms persisted for 2 years before the patient was admitted to the hospital
More in Cardiology
Advance of disease driven by high BMI, with social determinants of health playing a role
Endocrinologists urged to pay attention to COORDINATE trial
But GI side effects higher than other comparable anti-obesity agents
Recent developments of interest in cardiovascular medicine
Once-weekly CagriSema reduced body weight more than either agent alone
These were patients with "really debilitating diabetes," says investigator
Another study showed two high doses were better at reducing HbA1c vs a 14-mg dose
Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease
More positive results in CLEAR Outcomes sub-analysis
Superior to once-a-day insulin glargine U100 and degludec
Daily orforglipron also lowered HbA1c in type 2 diabetes
Phase IIb ENLIVEN trial saw success with various doses of pegozafermin
Researchers plan to improve accuracy of concept in future study
